Cite Filings / HRTX / 0000950170-25-105475
Feed Companies Filings Check
Sign in
10-Q

Quarterly Report

HERON THERAPEUTICS, INC. /DE/ · Filed 2025-08-08 · Acc 0000950170-25-105475

Documents 1

  • 10-Q Quarterly Report , hrtx-20250630.htm

Around this filing

  • 2025-11-04 10-Q Quarterly Report
  • 2025-08-08 10-Q Quarterly Report
  • 2025-08-08 8-K Material agreement · Results of operations · New debt or obligation · Unregistered share sale · Other events
  • 2025-08-04 4 EVP, Chief Development Officer acquired 11,695 shares (option exercise)
  • 2025-08-04 4 EVP, Chief Financial Officer acquired 11,695 shares (option exercise)
  • 2025-08-04 4 Chief Executive Officer acquired 34,789 shares (option exercise)
  • 2025-05-06 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading hrtx-20250630.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…